These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15959883)

  • 21. Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.
    Roberge C; Carpentier AC; Langlois MF; Baillargeon JP; Ardilouze JL; Maheux P; Gallo-Payet N
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1465-78. PubMed ID: 17911338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond.
    Lu JY; Huang KC; Chang LC; Huang YS; Chi YC; Su TC; Chen CL; Yang WS
    J Biomed Sci; 2008 Sep; 15(5):565-76. PubMed ID: 18535923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.
    Takamura T; Misu H; Matsuzawa-Nagata N; Sakurai M; Ota T; Shimizu A; Kurita S; Takeshita Y; Ando H; Honda M; Kaneko S
    Obesity (Silver Spring); 2008 Dec; 16(12):2601-9. PubMed ID: 18846047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance.
    Kaaman M; Rydén M; Axelsson T; Nordström E; Sicard A; Bouloumié A; Langin D; Arner P; Dahlman I
    Int J Obes (Lond); 2006 Mar; 30(3):447-52. PubMed ID: 16261187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity.
    Kypreos KE; Karagiannides I; Fotiadou EH; Karavia EA; Brinkmeier MS; Giakoumi SM; Tsompanidi EM
    FEBS J; 2009 Oct; 276(20):5720-8. PubMed ID: 19754875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
    Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid metabolism, exercise and insulin action.
    Bonen A; Dohm GL; van Loon LJ
    Essays Biochem; 2006; 42():47-59. PubMed ID: 17144879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance. Prosperity's plague.
    Taubes G
    Science; 2009 Jul; 325(5938):256-60. PubMed ID: 19608888
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
    Janovská A; Hatzinikolas G; Staikopoulos V; McInerney J; Mano M; Wittert GA
    Mol Cell Endocrinol; 2008 Mar; 284(1-2):1-10. PubMed ID: 18255222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Causes and natural course of obesity in man].
    Kather H
    Monatsschr Kinderheilkd; 1985 Jun; 133(6):404-8. PubMed ID: 3862955
    [No Abstract]   [Full Text] [Related]  

  • 34. The humoral side of insulin resistance.
    Lazar MA
    Nat Med; 2006 Jan; 12(1):43-4. PubMed ID: 16397562
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumour necrosis factor-alpha in human adipose tissue -- from signalling mechanisms to clinical implications.
    Rydén M; Arner P
    J Intern Med; 2007 Oct; 262(4):431-8. PubMed ID: 17875179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity-related derangements in metabolic regulation.
    Muoio DM; Newgard CB
    Annu Rev Biochem; 2006; 75():367-401. PubMed ID: 16756496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adipotoxicity and the insulin resistance syndrome.
    Anderwald C; Roden M
    Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endocrine function of adipose tissue: an update.
    Ronti T; Lupattelli G; Mannarino E
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):355-65. PubMed ID: 16584505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic consequences of lipodystrophy in mouse models.
    Reue K; Phan J
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):436-41. PubMed ID: 16778573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty acid metabolism in adipose tissue, muscle and liver in health and disease.
    Frayn KN; Arner P; Yki-Järvinen H
    Essays Biochem; 2006; 42():89-103. PubMed ID: 17144882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.